IGM Biosciences Stock Quote IGMS - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

6.50

Bid

6.51

Ask

8.00

Volume

400,437

6.455 Day's Range 7.41

0.00 52 Week Range 0.00

Market Cap

382.113M

Previous Close

7.24

Open

7.15

Last Trade

200

6.5

(formt)

Last Trade Time

16:59:31

Financial Volume

$ 2,703,548

VWAP

6.7515

Average Volume (3m)

Shares Outstanding

58,786,588

Dividend Yield

PE Ratio

-1.55

Earnings Per Share (EPS)

-4.19

Revenue

2.13M

Net Profit

-246.42M

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking ago... IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.igmbio.com

Headquarters

Dover, Delaware, USA

Founded

1970

IGM Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IGMS. The last closing price for IGM Biosciences was $7.24. Over the last year, IGM Biosciences shares have traded in a share price range of $ 0.00 to $ 0.00.

IGM Biosciences currently has 58,786,588 shares outstanding. The market capitalization of IGM Biosciences is $382.11 million. IGM Biosciences has a price to earnings ratio (PE ratio) of -1.55.

Form SC TO-I - Tender offer statement by Issuer

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SPECSpectaire Holdings Inc	$ 0.6499 (91.15%)	5.43M
SRPTSarepta Therapeutics Inc New	$ 167.67 (35.77%)	680.42k
LGHLWLion Group Holding Ltd	$ 0.0075 (15.38%)	21.05k
BRNSBarinthus Biotherapeutics PLC	$ 1.44 (15.20%)	2.53k
CODACoda Octopus Group Inc	$ 7.00 (14.75%)	454
RELIReliance Global Group Inc	$ 0.5104 (-15.48%)	1.59M
NTBLNotable Labs Ltd	$ 0.6801 (-9.56%)	20.18k
TRVNTrevena Inc	$ 0.2234 (-9.19%)	289.97k
DECADenali Capital Acquisition Corporation	$ 7.30 (-8.75%)	773
LDTCLeddarTech Holdings Inc	$ 0.874 (-8.58%)	500
ZCARZoomcar Holdings Inc	$ 0.167 (14.23%)	12.89M
NVDANVIDIA Corporation	$ 130.18 (-0.46%)	10.64M
KTRAKintara Therapeutics Inc	$ 0.3149 (14.55%)	10.31M
PBMPsyence Biomedical Ltd	$ 0.651 (8.50%)	8.48M
SPECSpectaire Holdings Inc	$ 0.6505 (91.32%)	5.39M